Pernix Therapeutics Holdings Inc. (Nasdaq: PTX) warned of lower second quarter revenue sending the stock price down $1.06 to close at $3.43.
Pernix Therapeutics warns of lower revenue
July 21, 2017 at 17:22 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|